Xifaxan (rifaximin) is now approved for preventing hepatic encephalopathy due to chronic liver disease
May 2010
Xifaxan (rifaximin) is now approved for preventing hepatic encephalopathy due to chronic liver disease....
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote